Clinical and myopathological evaluation of early- and late-onset subtypes of myofibrillar myopathy

dc.contributor.author
Olivé i Plana, Montserrat
dc.contributor.author
Odgerel, Zagaa
dc.contributor.author
Martínez, Amaia
dc.contributor.author
Poza, Juan José
dc.contributor.author
García Bragado, Federico
dc.contributor.author
Zabalza, Ramón J.
dc.contributor.author
Jericó, Ivonne
dc.contributor.author
González Mera, Laura
dc.contributor.author
Shatunov, Alexey
dc.contributor.author
Lee, Hee Suk
dc.contributor.author
Armstrong i Morón, Judith
dc.contributor.author
Maraví, Elías
dc.contributor.author
Ramos Arroyo, María
dc.contributor.author
Pascual Calvet, Jordi
dc.contributor.author
Navarro, Carmen
dc.contributor.author
Paradas, Carmen
dc.contributor.author
Huerta Villanueva, Mariano
dc.contributor.author
Márquez, Fabian
dc.contributor.author
Gutierrez Rivas, Eduardo
dc.contributor.author
Pou, Adolf
dc.contributor.author
Ferrer, Isidro (Ferrer Abizanda)
dc.contributor.author
Goldfarb, Lev G.
dc.date.issued
2018-11-21T09:07:36Z
dc.date.issued
2018-11-21T09:07:36Z
dc.date.issued
2011-06-14
dc.date.issued
2018-11-21T09:07:36Z
dc.identifier
0960-8966
dc.identifier
https://hdl.handle.net/2445/126272
dc.identifier
600948
dc.identifier
21676617
dc.description.abstract
Myofibrillar myopathies (MFM) are a group of disorders associated with mutations in DES, CRY A B, M YOT, ZASP, FLNC, or BAG3 genes and characterized by disintegration of myofibrils and accumulation of degradation products into intracellular inclusions. We retrospectively evaluated 53 M FM patients from 35 Spanish families. Studies included neurologic exam, muscle imaging, light and electron microscopic analysis of muscle biopsy, respiratory function testing and cardiologic work-up. Search for pathogenic mutations was accomplished by sequencing of coding regions of the six genes known to cause MFM. Mutations in M YOT were the predominant cause of MFM in Spain affecting 18 of 35 families, followed by DES in 11 and ZASP in 3; in 3 families the cause of MFM remains undetermined. Comparative analysis of DES, MYOT and ZASP associated phenotypes demonstrates substantial phenotypic distinctions that should be considered in studies of disease pathogenesis, for optimization of subtype-specific treatments and management, and directing molecular analysis. (C) 2011 Elsevier B.V. All rights reserved.
dc.format
10 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
Elsevier B.V.
dc.relation
Versió postprint del document publicat a: https://doi.org/10.1016/j.nmd.2011.05.002
dc.relation
Neuromuscular Disorders, 2011, vol. 21, num. 8, p. 533-542
dc.relation
https://doi.org/10.1016/j.nmd.2011.05.002
dc.rights
(c) Elsevier B.V., 2011
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject
Malalties musculars
dc.subject
Genètica
dc.subject
Malalties hereditàries
dc.subject
Espanya
dc.subject
Muscular Diseases
dc.subject
Genetics
dc.subject
Genetic diseases
dc.subject
Spain
dc.title
Clinical and myopathological evaluation of early- and late-onset subtypes of myofibrillar myopathy
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.